Home / Cancer and immune system / Golimumab
ATC L04AB06 · Immunosuppressants
Golimumab shortage
As of 31 Oct 2026, Golimumab has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Belgium), covering 6 products.
Countries3/5
Products6packs or presentations
Short since1 Mar 20268 months ago
Earliest return31 Oct 2026company estimate
No return date0products
Main reasonManufacturing problem
Timeline
GermanyItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Gotenfia | STADA Arzneimittel Aktiengesellschaft - Geschäftsanschrift - | 1 Mar 2026 | 3 May 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Gotenfia | STADA Arzneimittel Aktiengesellschaft - Geschäftsanschrift - | 1 Mar 2026 | 3 May 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Gotenfia | STADA Arzneimittel Aktiengesellschaft - Geschäftsanschrift - | 1 Mar 2026 | 3 May 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Gotenfia | STADA Arzneimittel Aktiengesellschaft - Geschäftsanschrift - | 1 Mar 2026 | 3 May 2027 | Manufacturing problem Probleme in der Herstellung |
| IT | GOBIVAZ announced | ADVANZ PHARMA LIMITED | 1 Dec 2026 | 20 Feb 2027 | Increased demand Elevata richiesta |
| BE | Simponi 50 mg (Orifarm) inj. sol. s.c. pre-filled pen 0.5 ml | Janssen-Cilag International | 10 Aug 2026 | 31 Oct 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.